Comparing Outcomes of a Digital Commercial Weight Loss Program in Adult Cancer Survivors and Matched Controls with Overweight or Obesity: Retrospective Analysis.
Adult
Aged
Breast Neoplasms
/ epidemiology
Cancer Survivors
Cross-Sectional Studies
Exercise
Female
Humans
Male
Middle Aged
Neoplasms
/ epidemiology
Obesity
/ epidemiology
Overweight
/ epidemiology
Quality of Life
Retrospective Studies
Surveys and Questionnaires
Treatment Outcome
Weight Loss
Weight Reduction Programs
/ methods
cancer survivors
obesity
retrospective study
weight loss
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
24 Aug 2021
24 Aug 2021
Historique:
received:
07
07
2021
revised:
16
08
2021
accepted:
19
08
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
16
11
2021
Statut:
epublish
Résumé
Maintaining a healthy weight is beneficial for cancer survivors. However, weight loss program effectiveness studies have primarily been in highly controlled settings. This is a retrospective study exploring real-world outcomes (weight loss and program engagement) after use of a digital commercial weight loss program (Noom) in cancer survivors and matched controls. All participants had voluntarily self-enrolled in Noom. Weight and engagement data were extracted from the program. Cancer-related quality of life was secondarily assessed in a one-time cross-sectional survey for survivors. Controls were a sample of Noom users with overweight/obesity who had no history of cancer but 0-1 chronic conditions. Primary outcomes were weight change at 16 weeks and program engagement over 16 weeks. Engagement included frequency of weight, food, and physical activity logging, as well as number of coach messages. Multiple regression controlling for baseline age, gender, engagement, and BMI showed that survivors lost less weight than controls (B = -2.40, s.e. = 0.97,
Identifiants
pubmed: 34578787
pii: nu13092908
doi: 10.3390/nu13092908
pmc: PMC8470305
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Références
Obes Rev. 2020 Jul;21(7):e13013
pubmed: 32181957
Breast Cancer Res Treat. 2012 Feb;132(1):205-13
pubmed: 22113257
Health Commun. 2020 Dec;35(14):1791-1799
pubmed: 31514532
Obes Rev. 2007 Jul;8(4):307-26
pubmed: 17578381
Public Health Nutr. 2019 Apr;22(6):1019-1028
pubmed: 30449294
Women Health. 2015;55(5):505-24
pubmed: 25833659
JMIR Mhealth Uhealth. 2020 Sep 21;8(9):e18867
pubmed: 32955446
Int J Nurs Stud. 2014 Dec;51(12):1557-67
pubmed: 24856854
Oncol Nurs Forum. 2011 Mar;38(2):E97-106
pubmed: 21356647
J Clin Epidemiol. 2014 Aug;67(8):845-9
pubmed: 24766858
Nutr Bull. 2017 Sep;42(3):246-253
pubmed: 29151813
Int J Obes (Lond). 2017 Jan;41(1):200-202
pubmed: 27780974
PLoS One. 2020 Apr 13;15(4):e0231229
pubmed: 32282816
Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1262-9
pubmed: 26178712
BMC Public Health. 2016 Jan 29;16:91
pubmed: 26825583
Endocrinol Metab Clin North Am. 2008 Dec;37(4):905-22
pubmed: 19026939
Transl Behav Med. 2020 Oct 8;10(4):938-948
pubmed: 30535101
Transl Behav Med. 2017 Jun;7(2):254-267
pubmed: 27966189
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
Eur J Cancer. 2002 Mar;38 Suppl 4:S125-33
pubmed: 11858978
Support Care Cancer. 2014 Aug;22(8):2057-65
pubmed: 24633590
Obes Rev. 2011 Sep;12(9):688-708
pubmed: 21535362
Obes Facts. 2011;4(2):113-20
pubmed: 21577018
J Cancer Surviv. 2017 Dec;11(6):704-719
pubmed: 28779220
JMIR Diabetes. 2020 Jun 4;5(2):e18363
pubmed: 32497017
Nutrition. 2020 Mar;71:110622
pubmed: 31837644
Gynecol Oncol. 2015 Jun;137(3):508-15
pubmed: 25681782
Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1244-59
pubmed: 22695735
Curr Breast Cancer Rep. 2013 Sep;5(3):222-246
pubmed: 26605003
Obes Facts. 2018;11(1):67-82
pubmed: 29439252
Disabil Rehabil. 2013;35(24):2038-45
pubmed: 23772995
Colorectal Dis. 2013 Aug;15(8):949-57
pubmed: 23480570
JMIR Mhealth Uhealth. 2020 Jul 8;8(7):e17842
pubmed: 32459631
Nutrients. 2021 May 20;13(5):
pubmed: 34065277
Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1029-36
pubmed: 27371756
Obes Rev. 2006 Nov;7(4):333-40
pubmed: 17038127
Psychooncology. 2018 Jan;27(1):22-33
pubmed: 29044832
J Cancer Surviv. 2017 Jun;11(3):360-385
pubmed: 28097452
Int J Med Sci. 2012;9(2):163-73
pubmed: 22275855